HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 394: | Line 394: | ||
|4/15/25 | |4/15/25 | ||
| | | | ||
| | |Complete (pending MS review) | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 480: | Line 480: | ||
|4/15/25 | |4/15/25 | ||
| | | | ||
| | |Complete (pending MS review) | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 509: | Line 509: | ||
|[[HAEM5:Acute myeloid leukaemia with other defined genetic alterations|Acute myeloid leukaemia with other defined genetic alterations]] | |[[HAEM5:Acute myeloid leukaemia with other defined genetic alterations|Acute myeloid leukaemia with other defined genetic alterations]] | ||
|Disease | |Disease | ||
|Mehak Samreen (trainee); Malini Sathanoori Ph.D. | |||
|03/02/26 | |||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 2,517: | Line 2,517: | ||
|9/24/2025 | |9/24/2025 | ||
|12/9/2025 | |12/9/2025 | ||
|Complete | |'''Complete''' | ||
| 12/17/2025||SK|| || | | 12/17/2025||SK|| 1/6/2026|| | ||
|Chronic Lymphoproliferative Disorder of NK Cells | |Chronic Lymphoproliferative Disorder of NK Cells | ||
|Michelle Don, MD | |Michelle Don, MD | ||
| Line 2,733: | Line 2,733: | ||
|9/24/2025 | |9/24/2025 | ||
|11/9/2025 | |11/9/2025 | ||
|Complete | |'''Complete''' | ||
|12/17/2025 | |12/17/2025 | ||
|SK||1/6/2026|| | |||
|SK|| | |||
|Hepatosplenic T-cell Lymphoma | |Hepatosplenic T-cell Lymphoma | ||
|Michelle Don, MD, MS | |Michelle Don, MD, MS | ||
| Line 2,840: | Line 2,839: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Extranodal NK/T-cell lymphoma|Extranodal NK/T-cell lymphoma]]||Disease||Ian King, PhD | |[[HAEM5:Extranodal NK/T-cell lymphoma|Extranodal NK/T-cell lymphoma]]||Disease||Maryam Mehdiopour Dalivand (trainee); Ian King, PhD | ||
|1/6/2026 | |1/6/2026 | ||
| 2/3/2026||Pending | | 2/3/2026||Pending | ||